Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
AACR 2023
MedTech
AACR: Adela's cancer blood test shows promise in early stages
Canadian newcomer Adela has shown that its test for detecting the faint traces of cancer in the bloodstream could spot 12 types of the disease.
Conor Hale
Apr 18, 2023 11:38am
Kinnate ends cancer data wait but fails to captivate investors
Apr 18, 2023 8:55am
AACR: New Affimed data disappoints after Nasdaq flags stock dip
Apr 17, 2023 12:52pm
AACR: Merck, Moderna plan for phase 3 cancer vax trial in '23
Apr 16, 2023 11:00am
